Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Precigen Inc.
Jun 11, 2020
Precigen to Participate in Upcoming JMP Securities Hematology and Oncology Forum
Jun 04, 2020
Notice: Precigen Announces Date and Location Change for its 2020 Annual Meeting of Shareholders
May 06, 2020
Precigen Reports First Quarter 2020 Financial Results
Apr 29, 2020
Precigen to Announce First Quarter 2020 Financial Results on May 6th
Apr 20, 2020
Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse(TM) Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors
Feb 24, 2020
Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd
Jan 06, 2020
Precigen Receives FDA Orphan Drug Designation for PRGN-3006 UltraCAR-T(TM) in Patients with Acute Myeloid Leukemia (AML)
Jan 02, 2020
Intrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen To Reflect Healthcare Focus
Aug 05, 2019
Precigen Announces First Patient Dosed in Phase 1 Study of PRGN-3005 UltraCAR-T(TM) in Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Jun 13, 2019
Intrexon's Subsidiary Precigen to Present at the JMP Securities Life Sciences Conference
Feb 20, 2019
Intrexon's Subsidiary Precigen to Present at the SVB Leerink 8th Annual Global Healthcare Conference
Feb 11, 2019
Precigen Announces Clearance of IND to Initiate Phase 1 Study for First-in-Class PRGN-3005 UltraCAR-T(TM) to Treat Advanced Stage Platinum Resistant Ovarian Cancer Patients
Dec 31, 2018
Precigen to Debut Portfolio at Investor Event during the 37th Annual J.P. Morgan Healthcare Conference
Dec 21, 2018
Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for First-in-Class PRGN-3006 UltraCAR-T(TM) Therapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) and Higher Risk Myelodysplastic Syndrome (MDS)
May 21, 2018
Precigen Announces First Patient Dosed in Phase 1 Clinical Study of INXN-4001
Jun 29, 2017
Intrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and Development of Precigen
Latest News
Mar 29, 2024
Global Automotive Semiconductor Market Outlook & Forecast 2023-2028: A Highly Fragmented $135 Bn Market...
Mar 29, 2024
Zep® Launches Fume Free Air Fryer & Oven Cleaner for the Modern Kitchen; Now Available Throughout the...
Mar 29, 2024
UC Berkeley FHL Vive Center Teams Up with BeamNG
Mar 29, 2024
University of Phoenix Receives Arizona Veteran Supportive Campus Recertification
Mar 29, 2024
PCI Announces Expansion of Mail Presort Operations to the Midwest, Boosting National Presence, Regional...
Mar 29, 2024
New Report Shows Massachusetts Customers Could Have Saved Hundreds of Millions in 2024 Through Competitive...
Mar 29, 2024
Global Surface Materials for Transportation Market Report 2024-2033: Growing Demand for Customization,...
Mar 29, 2024
Impacts of Extreme Weather on Interior Design Examined in New Research
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events